Metabolic Profiles in Urine Reflect Nephrotoxicity of Sirolimus and Cyclosporine following Rat Kidney Transplantation

被引:38
作者
Schmitz, Volker [1 ,3 ]
Klawitter, Jost [2 ,3 ,6 ]
Bendrick-Peart, Jamie [6 ]
Schoening, Wenzel [1 ]
Puhl, Gero [1 ]
Haschke, Manuel [3 ]
Klawitter, Jelena [2 ,3 ]
Consoer, Jeff [3 ]
Rivard, Christopher J. [4 ]
Chan, Laurence [4 ]
Tran, Zung V. [5 ]
Leibfritz, Dieter [2 ]
Christians, Uwe [3 ,6 ]
机构
[1] Charite, Dept Gen Visceral & Transplantat Surg, DE-13353 Berlin, Germany
[2] Univ Bremen, Inst Organ Chem, Bremen, Germany
[3] Univ Colorado, Dept Anesthesiol, Denver, CO 80202 USA
[4] Univ Colorado, Dept Renal Dis & Hypertens, Denver, CO 80202 USA
[5] Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80202 USA
[6] Eurofins Medinet, Aurora, CO USA
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2009年 / 111卷 / 04期
基金
美国国家卫生研究院;
关键词
Cyclosporine; Sirolimus; Nephrotoxicity; Ischemia reperfusion; Urine metabolic profiles; Kidney transplantation; IMPROVED RENAL-FUNCTION; MAGNETIC-RESONANCE; IN-VIVO; MITOCHONDRIAL METABOLISM; ALLOGRAFT DYSFUNCTION; NMR-SPECTROSCOPY; OXIDATIVE STRESS; MTOR INHIBITORS; RECOVERY; QUANTIFICATION;
D O I
10.1159/000209208
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Cyclosporine and/or sirolimus impair recovery of renal transplants. This study examines the changes in urine metabolite profiles as surrogate markers of renal cell metabolism and function after cyclosporine and/or sirolimus treatment employing a rat kidney transplantation model. Methods: Using inbred Lewis rats, kidneys were transplanted into bilaterally nephrectomized recipients followed by treatment with either CsA (cyclosporine) 10, Rapa (sirolimus) 1, CsA10/Rapa1 or CsA25/Rapa1 mg/kg/day for 7 days. On day 7, urine was analyzed by H-1-NMR spectroscopy. Blood and kidney tissue drug concentrations, tissue high-energy compounds (including ATP, ADP) and oxidative stress markers (15-F-2t-isoprostanes) in urine were measured by HPLC mass spectrometry. Results: Changes in urine metabolites followed the order Rapa1 < CsA10 < CsA10/Rapa1 < CsA25/Rapa1. Compared with controls, CsA25/Rapa1 showed the greatest changes (creatinine -36%, succinate -57%, citrate -89%, alpha-ketoglutarate -75%, creatine + 498%, trimethylamine + 210% and taurine + 370%). 15-F-2t-isoprostane concentrations in urine increased in the combined immunosuppressant-treated animals ([CsA25/Rapa1]: 795 +/- 222, [CsA10/Rapa1]: 475 +/- 233 pg/mg/creatinine) as compared with controls (165 +/- 78 pg/mg creatinine). Rapa concentration in blood and tissues increased in the combined treatment (blood: 31 +/- 8 ng/ml, tissue: 1.3 +/- 0.4 ng/mg) as compared with monotherapy (blood: 14 +/- 8 ng/ml, tissue: 0.35 +/- 0.15 ng/mg). Drug blood concentrations correlated with isoprostane urine concentrations, which correlated negatively with citrate, alpha-ketoglutarate and creatinine concentrations in urine. Only CsA25/Rapa1 significantly reduced high-energy metabolite concentrations in transplant kidney tissue (ATP -55%, ADP -24%). Conclusion: Immunosuppressant drugs induce changes in urine metabolite patterns, suggesting that immunosuppressant-induced oxidative stress is an early event in the development of nephrotoxicity. Urine 15F(2t)-isoprostane concentrations and me tabolite profiles may be sensitive markers of immunosuppressant-induced nephrotoxicity. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:E80 / E91
页数:12
相关论文
共 47 条
  • [1] Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model
    Andoh, TF
    Lindsley, J
    Franceschini, N
    Bennett, WM
    [J]. TRANSPLANTATION, 1996, 62 (03) : 311 - 316
  • [2] STUDIES ON THE COMPARATIVE TOXICITY OF S-(1,2-DICHLOROVINYL)-L-CYSTEINE, S-(1,2-DICHLOROVINYL)-L-HOMOCYSTEINE AND 1,1,2-TRICHLORO-3,3,3-TRIFLUORO-1-PROPENE IN THE FISCHER-344 RAT
    ANTHONY, ML
    BEDDELL, CR
    LINDON, JC
    NICHOLSON, JK
    [J]. ARCHIVES OF TOXICOLOGY, 1994, 69 (02) : 99 - 110
  • [3] Bairaktari E, 1998, CLIN CHEM, V44, P1256
  • [4] Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage
    Brook, NR
    Waller, JR
    Bicknell, GR
    Nicholson, ML
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 837 - 838
  • [5] DISSOCIATION OF DECREASES IN RENAL CELLULAR ENERGETICS AND RECOVERY OF RENAL MICROSOMAL TRANSLATION DURING CHRONIC CYCLOSPORINE-A ADMINISTRATION
    BUSS, WC
    GRIFFEY, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1991, 42 (01) : 71 - 76
  • [6] Campistol JM, 2001, TRANSPLANTATION, V71, pSS42
  • [7] CHAN L, 1989, RENAL PHYSIOL BIOCH, V12, P181
  • [8] Chronic renal allograft dysfunction
    Chapman, JR
    O'Connell, PJ
    Nankivell, BJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (10): : 3015 - 3026
  • [9] Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants
    Christians, U
    Jacobsen, W
    Serkova, N
    Benet, LZ
    Vidal, C
    Sewing, KF
    Manns, MP
    Kirchner, GI
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 748 (01): : 41 - 53
  • [10] Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors
    Christians, U
    Gottschalk, S
    Miljus, J
    Hainz, C
    Benet, LZ
    Leibfritz, D
    Serkova, N
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (03) : 388 - 396